NCT05969041View on ClinicalTrials.gov

Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 2, 2023

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2028

Conditions
Epithelial Tumors, Malignant
Interventions
DRUG

MT-302 (A)

MT-302 is an investigational drug

Trial Locations (6)

2010

RECRUITING

St Vincent's Public Hospital Sydney, Darlinghurst

2031

RECRUITING

Scientia Clinical Research Ltd, Randwick

2145

RECRUITING

Westmead Hospital, Westmead

3144

RECRUITING

Cabrini Health, Malvern

5042

RECRUITING

Souther Oncology Clinical Research Unit (SOCRU), Bedford Park

6009

RECRUITING

Linear Clinical Research Ltd, Nedlands

Sponsors
All Listed Sponsors
lead

Myeloid Therapeutics

INDUSTRY